Tilray | TRLY - Market Capitalization


Tilray reported $4.7B in Market Capitalization this July of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Akebia Therapeutics USD 427M 297M Dec/2025
Alaunos Therapeutics USD 7M 2M Mar/2026
Aurora Cannabis CAD 193.82M 133.39M Mar/2026
Avita Medical AUD 105.47M 35.32M Dec/2025
Canopy Growth CAD 125.74M 431.39M Jul/2026
Cronos Group USD 958.02M 45.05M Mar/2026
Dianthus Therapeutics USD 2.71B 1.87B Jul/2026
Divis Laboratories Ltd INR 1.58T 118.27B Mar/2026
Ionis Pharmaceuticals USD 12.46B 356M Mar/2026
IQVIA Holdings USD 28.63B 9.76B Mar/2026
Moderna USD 20.15B 8.53B Mar/2026
Organigram Holdings CAD 136.51M 115.96M Jul/2026
Organon & Co USD 3.47B 1.9B Jul/2026
Revvity USD 9.94B 1.03B Mar/2026
Tectonic Therapeutic USD 510M 70M Jul/2026
Viatris USD 15.73B 1.39B Mar/2026
Xeris Pharmaceuticals USD 1.11B 112M Jul/2026
Zealand Pharma A/S 33.35B 448.34M Dec/2025